Faculty
Oncology Division
Alphabetical list (active faculty):   
Iskra Pusic

Iskra Pusic, MD

Associate Professor

Department of Medicine

Oncology Division

Bone Marrow Transplantation & Leukemia

Clinical Interests

  • Hematologic malignancies
  • Hematopoietic stem cell transplantation
  • Chronic graft-versus-host disease

Research Interests

  • Chronic graft-versus-host disease
  • Graft-versus-tumor effects
  • Transplant biology

Contact

  • 314-454-8306 (office)
  • 314-454-7551 (fax)
  • Division of Oncology
    Mail Stop 8007-0029-11
    Washington University
    660 South Euclid Avenue
    St. Louis, MO 63110
  • 11th Floor Mid-Campus Center (office)

Peer-reviewed Publications

  • Lessons Learned From Early Closure of a Clinical Trial for Steroid-Refractory Acute GVHD
    Meyers G, Hamadani M, Martens M, Ali H, Choe H, Dawson P, Harris AC, van Hooren E, Klaassen W, Leifer E, MacMillan ML, van Oosterhout Y, Perez L, Pusic I, Vo P, Levine JE
    Bone Marrow Transplant 2021 Nov 23; [Epub ahead of print]
  • Systemic IL-15 Promotes Allogeneic Cell Rejection in Patients Treated With Natural Killer Cell Adoptive Therapy
    Berrien-Elliott MM, Becker-Hapak M, Cashen AF, Jacobs MT, Wong P, Foster M, McClain E, Desai S, Pence P, Cooley S, Brunstein CG, Gao F, Abboud CN, Uy GL, Westervelt P, Jacoby MA, Pusic I, Stockerl-Goldstein K, Schroeder MA, DiPersio JF, Soon-Shiong P, Miller JS, Fehniger TA
    Blood 2021 Nov 19; [Epub ahead of print]
  • Initial Therapy for Chronic Graft-Versus-Host Disease: Analysis of Practice Variation and Failure-Free Survival
    Pidala J, Onstad L, Martin PJ, Hamilton BK, Cutler C, Kitko CL, Carpenter PA, Chen GL, Arora M, Flowers MED, Arai S, Alousi A, White J, Jacobsohn D, Pusic I, Lee SJ
    Blood Adv 2021 Nov 23;5(22):4549-4559
  • Germinal Centre-Driven Maturation of B Cell Response to SARS-CoV-2 Vaccination
    Kim W, Zhou JQ, Sturtz AJ, Horvath SC, Schmitz AJ, Lei T, Kalaidina E, Thapa M, Alsoussi WB, Haile A, Klebert MK, Suessen T, Parra-Rodriguez L, Mudd PA, Middleton WD, Teefey SA, Pusic I, O'Halloran JA, Presti RM, Turner JS, Ellebedy AH
    bioRxiv 2021 Nov 2:466651
  • Combination of Dociparstat Sodium (DSTAT), a CXCL12/CXCR4 Inhibitor, With Azacitidine for the Treatment of Hypomethylating Agent Refractory AML and MDS
    Huselton E, Rettig MP, Campbell K, Cashen AF, DiPersio JF, Gao F, Jacoby MA, Pusic I, Romee R, Schroeder MA, Uy GL, Marcus S, Westervelt P
    Leuk Res 2021 Nov;110:106713
  • Beyond Ruxolitinib in Steroid-Refractory Acute Graft-Versus-Host Disease
    Lee CJ, Pusic I, Savani BN
    Br J Haematol 2021 Nov;195(3):306-307
  • Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia
    Desai PM, Brown J, Gill S, Solh MM, Akard LP, Hsu JW, Ustun C, Andreadis C, Frankfurt O, Foran JM, Lister J, Schiller GJ, Wieduwilt MJ, Pagel JM, Stiff PJ, Liu D, Khan I, Stock W, Kambhampati S, Tallman MS, Morris L, Edwards J, Pusic I, Kantarjian HM, Mamelok R, Wong A, Van Syoc R, Kellerman L, Panuganti S, Mandalam R, Abboud CN, Ravandi F
    J Clin Oncol 2021 Oct 10;39(29):3261-3272
  • Challenges in Conducting Studies in Chronic Graft-Versus-Host Disease
    Pusic I, Pavletic SZ
    Clin Hematol Int 2019 Mar 18;1(1):36-44
  • Relevance of Plasma Matrix Metalloproteinase-9 for Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation
    Inamoto Y, Martin PJ, Onstad LE, Cheng GS, Williams KM, Pusic I, Ho VT, Arora M, Pidala J, Flowers MED, Gooley TA, Lawler RL, Hansen JA, Lee SJ
    Transplant Cell Ther 2021 Sep;27(9):759e1-759e8
  • Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy
    Kharfan-Dabaja MA, Kumar A, Ayala E, Aljurf M, Nishihori T, Marsh R, Burroughs LM, Majhail N, Al-Homsi AS, Al-Kadhimi ZS, Bar M, Bertaina A, Boelens JJ, Champlin R, Chaudhury S, DeFilipp Z, Dholaria B, El-Jawahri A, Fanning S, Fraint E, Gergis U, Giralt S, Hamilton BK, Hashmi SK, Horn B, Inamoto Y, Jacobsohn DA, Jain T, Johnston L, Kanate AS, Kansagra A, Kassim A, Kean LS, Kitko CL, Knight-Perry J, Kurtzberg J, Liu H, MacMillan ML, Mahmoudjafari Z, Mielcarek M, Mohty M, Nagler A, Nemecek E, Olson TS, Oran B, Perales MA, Prockop SE, Pulsipher MA, Pusic I, Riches ML, Rodriguez C, Romee R, Rondon G, Saad A, Shah N, Shaw PJ, Shenoy S, Sierra J, Talano J, Verneris MR, Veys P, Wagner JE, Savani BN, Hamadani M, Carpenter PA
    Transplant Cell Ther 2021 Aug;27(8):642-649
  • Belumosudil for Chronic Graft-Versus-Host Disease (CGVHD) After 2 or More Prior Lines of Therapy: The ROCKstar Study
    Cutler CS, Lee SJ, Arai S, Rotta M, Zoghi B, Lazaryan A, Ramakrishnan A, DeFilipp Z, Salhotra A, Chai-Ho W, Mehta RS, Wang T, Arora M, Pusic I, Saad A, Shah NN, Abhyankar S, Bachier C, Galvin JP, Im A, Langston A, Liesveld JL, Juckett M, Logan A, Schachter L, Alavi A, Howard DS, Waksal H, Ryan J, Eiznhamer D, Aggarwal SK, Ieyoub J, Schueller O, Green LS, Yang Z, Krenz H, Jagasia M, Blazar BR, Pavletic SZ
    Blood 2021 Jul 15; [Epub ahead of print]
  • SARS-CoV-2 Infection Induces Long-Lived Bone Marrow Plasma Cells in Humans
    Turner JS, Kim W, Kalaidina E, Goss CW, Rauseo AM, Schmitz AJ, Hansen L, Haile A, Klebert MK, Pusic I, O'Halloran JA, Presti RM, Ellebedy AH
    Nature 2021 Jul;595(7867):421-425
  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report
    Williams KM, Inamoto Y, Im A, Hamilton B, Koreth J, Arora M, Pusic I, Mays JW, Carpenter PA, Luznik L, Reddy P, Ritz J, Greinix H, Paczesny S, Blazar BR, Pidala J, Cutler C, Wolff D, Schultz KR, Pavletic SZ, Lee SJ, Martin PJ, Socie G, Sarantopoulos S
    Transplant Cell Ther 2021 Jun;27(6):452-466
  • Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia
    Barnell EK, Newcomer KF, Skidmore ZL, Krysiak K, Anderson SR, Wartman LD, Oh ST, Welch JS, Stockerl-Goldstein KE, Vij R, Cashen AF, Pusic I, Westervelt P, Abboud CN, Ghobadi A, Uy GL, Schroeder MA, DiPersio JF, Politi MC, Spencer DH, Duncavage EJ, Ley TJ, Griffith M, Jacoby MA, Griffith OL
    JCO Precis Oncol 2021 Jan 14;5
  • A Randomized Phase 2 Trial of Pomalidomide in Subjects Failing Prior Therapy for Chronic Graft-Versus-Host Disease
    Curtis LM, Ostojic A, Venzon DJ, Holtzman NG, Pirsl F, Kuzmina ZJ, Baird K, Rose JJ, Cowen EW, Mays JW, Mitchell SA, Parsons-Wandell L, Joe GO, Comis LE, Berger A, Pusic I, Peer CJ, Figg WD, Cao L, Gale RP, Hakim FT, Pavletic SZ
    Blood 2021 Feb 18;137(7):896-907
  • SARS-CoV-2 Infection Induces Long-Lived Bone Marrow Plasma Cells in Humans
    Ellebedy A, Turner J, Kim W, Kalaidina E, Goss C, Rauseo A, Schmitz A, Hansen L, Haile A, Klebert M, Pusic I, O'Halloran J, Presti R
    Res Sq 2020 Dec 31
  • Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
    Deininger MW, Shah NP, Altman JK, Berman E, Bhatia R, Bhatnagar B, DeAngelo DJ, Gotlib J, Hobbs G, Maness L, Mead M, Metheny L, Mohan S, Moore JO, Naqvi K, Oehler V, Pallera AM, Patnaik M, Pratz K, Pusic I, Rose MG, Smith BD, Snyder DS, Sweet KL, Talpaz M, Thompson J, Yang DT, Gregory KM, Sundar H
    J Natl Compr Canc Netw 2020 Oct 1;18(10):1385-1415
  • Cardio-Oncology Care in the Era of the Coronavirus Disease 2019 (COVID-19) Pandemic: An International Cardio-Oncology Society (ICOS) Statement
    Lenihan D, Carver J, Porter C, Liu JE, Dent S, Thavendiranathan P, Mitchell JD, Nohria A, Fradley MG, Pusic I, Stockerl-Goldstein K, Blaes A, Lyon AR, Ganatra S, Lopez-Fernandez T, O'Quinn R, Minotti G, Szmit S, Cardinale D, Alvarez-Cardona J, Curigliano G, Neilan TG, Herrmann J
    CA Cancer J Clin 2020 Nov;70(6):480-504
  • Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations With Response After Adoptive Immunotherapy for Leukemia
    Berrien-Elliott MM, Cashen AF, Cubitt CC, Neal CC, Wong P, Wagner JA, Foster M, Schappe T, Desai S, McClain E, Becker-Hapak M, Foltz JA, Cooper ML, Jaeger N, Srivatsan SN, Gao F, Romee R, Abboud CN, Uy GL, Westervelt P, Jacoby MA, Pusic I, Stockerl-Goldstein KE, Schroeder MA, DiPersio J, Fehniger TA
    Cancer Discov 2020 Dec;10(12):1854-1871
  • Ixazomib for Treatment of Refractory Chronic Graft-Versus-Host Disease: A Chronic GVHD Consortium Phase II Trial
    Pidala J, Bhatt VR, Hamilton B, Pusic I, Wood WA, Onstad L, Hall AM, Storer B, Lee SJ
    Biol Blood Marrow Transplant 2020 Sep;26(9):1612-1619
  • Selinexor Combined With Cladribine, Cytarabine, and Filgrastim in Relapsed or Refractory Acute Myeloid Leukemia
    Abboud R, Chendamarai E, Rettig MP, Trinkaus KM, Riedell PA, Abboud CN, Ghobadi A, Pusic I, Stockerl-Goldstein K, Schroeder MA, Vij R, Westervelt P, DiPersio JF, Uy GL
    Haematologica 2020 Aug;105(8):e404-e407
  • Engraftment of Rare, Pathogenic Donor Hematopoietic Mutations in Unrelated Hematopoietic Stem Cell Transplantation
    Wong WH, Bhatt S, Trinkaus K, Pusic I, Elliott K, Mahajan N, Wan F, Switzer GE, Confer DL, DiPersio JF, Pulsipher MA, Shah NN, Sees J, Bystry A, Blundell JR, Shaw BE, Druley TE
    Sci Transl Med 2020 Jan 15;12(526)
  • Refined National Institutes of Health Response Algorithm for Chronic Graft-Versus-Host Disease in Joints and Fascia
    Inamoto Y, Lee SJ, Onstad LE, Flowers MED, Hamilton BK, Jagasia MH, Martin PJ, Pavletic SZ, Pidala JA, Pusic I, Vogelsang GB, Wolff D, Carpenter PA
    Blood Adv 2020 Jan 14;4(1):40-46
  • Ruxolitinib for Steroid-Refractory Acute Graft-Versus-Host Disease
    Toama W, Fiala MA, Pusic I, Westervelt P, DiPersio JF, Schroeder MA
    Transpl Int 2020 Feb;33(2):244-246
  • Randomized Multicenter Trial of Sirolimus Vs Prednisone as Initial Therapy for Standard-Risk Acute GVHD: The BMT CTN 1501 Trial
    Pidala J, Hamadani M, Dawson P, Martens M, Alousi AM, Jagasia M, Efebera YA, Chhabra S, Pusic I, Holtan SG, Ferrara JLM, Levine JE, Mielcarek M, Anasetti C, Antin JH, Bolanos-Meade J, Howard A, Logan BR, Leifer ES, Pritchard TS, Horowitz MM, MacMillan ML
    Blood 2020 Jan 9;135(2):97-107
  • The Use of Ruxolitinib for Acute Graft-Versus-Host Disease Developing After Solid Organ Transplantation
    Jacobs MT, Olson M, Ferreira BP, Jin RU, Hachem R, Byers D, Witt C, Ghobadi A, DiPersio JF, Pusic I
    Am J Transplant 2020 Feb;20(2):589-592
  • Ibrutinib for Chronic Graft-Versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study
    Waller EK, Miklos D, Cutler C, Arora M, Jagasia MH, Pusic I, Flowers MED, Logan AC, Nakamura R, Chang S, Clow F, Lal ID, Styles L, Jaglowski S
    Biol Blood Marrow Transplant 2019 Oct;25(10):2002-2007
  • Association of Leukemia Cutis With Survival in Acute Myeloid Leukemia
    Wang CX, Pusic I, Anadkat MJ
    JAMA Dermatol 2019 Jul 1;155(7):826-832
  • Challenges in Conducting Studies in Chronic Graft-versus-Host Disease
    Pusic I, Pavletic SZ
    Clinical Hematology International 2019 Mar 1(1):36-44
  • Three Prophylaxis Regimens (Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide; Tacrolimus, Methotrexate, and Bortezomib; or Tacrolimus, Methotrexate, and Maraviroc) Versus Tacrolimus and Methotrexate for Prevention of Graft-Versus-Host Disease With Haemopoietic Cell Transplantation With Reduced-Intensity Conditioning: A Randomised Phase 2 Trial With a Non-Randomised Contemporaneous Control Group (BMT CTN 1203)
    Bolanos-Meade J, Reshef R, Fraser R, Fei M, Abhyankar S, Al-Kadhimi Z, Alousi AM, Antin JH, Arai S, Bickett K, Chen YB, Damon LE, Efebera YA, Geller NL, Giralt SA, Hari P, Holtan SG, Horowitz MM, Jacobsohn DA, Jones RJ, Liesveld JL, Logan BR, MacMillan ML, Mielcarek M, Noel P, Pidala J, Porter DL, Pusic I, Sobecks R, Solomon SR, Weisdorf DJ, Wu J, Pasquini MC, Koreth J
    Lancet Haematol 2019 Mar;6(3):e132-e143
  • Mutation Clearance After Transplantation for Myelodysplastic Syndrome
    Duncavage EJ, Jacoby MA, Chang GS, Miller CA, Edwin N, Shao J, Elliott K, Robinson J, Abel H, Fulton RS, Fronick CC, O'Laughlin M, Heath SE, Brendel K, Saba R, Wartman LD, Christopher MJ, Pusic I, Welch JS, Uy GL, Link DC, DiPersio JF, Westervelt P, Ley TJ, Trinkaus K, Graubert TA, Walter MJ
    N Engl J Med 2018 Sep 13;379(11):1028-1041
  • Amphiregulin Modifies the Minnesota Acute Graft-Versus-Host Disease Risk Score: Results From BMT CTN 0302/0802
    Holtan SG, DeFor TE, Panoskaltsis-Mortari A, Khera N, Levine JE, Flowers MED, Lee SJ, Inamoto Y, Chen GL, Mayer S, Arora M, Palmer J, Cutler CS, Arai S, Lazaryan A, Newell LF, Jagasia MH, Pusic I, Wood WA, Renteria AS, Yanik G, Hogan WJ, Hexner E, Ayuk F, Holler E, Bunworasate U, Efebera YA, Ferrara JLM, Pidala J, Howard A, Wu J, Bolanos-Meade J, Ho V, Alousi A, Blazar BR, Weisdorf DJ, MacMillan ML
    Blood Adv 2018 Aug 14;2(15):1882-1888
  • Subclones Dominate at MDS Progression Following Allogeneic Hematopoietic Cell Transplant
    Jacoby MA, Duncavage EJ, Chang GS, Miller CA, Shao J, Elliott K, Robinson J, Fulton RS, Fronick CC, O'Laughlin M, Heath SE, Pusic I, Welch JS, Link DC, DiPersio JF, Westervelt P, Ley TJ, Graubert TA, Walter MJ
    JCI Insight 2018 Mar 8;3(5)
  • Ruxolitinib: A Steroid Sparing Agent in Chronic Graft-Versus-Host Disease
    Khoury HJ, Langston AA, Kota VK, Wilkinson JA, Pusic I, Jillella A, Bauer S, Kim AS, Roberts D, Al-Kadhimi Z, Bodo I, Winton E, Arellano M, DiPersio JF
    Bone Marrow Transplant 2018 Jul;53(7):826-831
  • Patterns of Infectious Complications in Acute Myeloid Leukemia and Myelodysplastic Syndromes Patients Treated With 10-Day Decitabine Regimen
    Ali AM, Weisel D, Gao F, Uy GL, Cashen AF, Jacoby MA, Wartman LD, Ghobadi A, Pusic I, Romee R, Fehniger TA, Stockerl-Goldstein KE, Vij R, Oh ST, Abboud CN, Schroeder MA, Westervelt P, DiPersio JF, Welch JS
    Cancer Med 2017 Dec;6(12):2814-2821
  • Ibrutinib for Chronic Graft-Versus-Host Disease After Failure of Prior Therapy
    Miklos D, Cutler CS, Arora M, Waller EK, Jagasia M, Pusic I, Flowers ME, Logan AC, Nakamura R, Blazar BR, Li Y, Chang S, Lal I, Dubovsky J, James DF, Styles L, Jaglowski S
    Blood 2017 Nov 23;130(21):2243-2250
  • TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Welch JS, Petti AA, Miller CA, Fronick CC, O'Laughlin M, Fulton RS, Wilson RK, Baty JD, Duncavage EJ, Tandon B, Lee YS, Wartman LD, Uy GL, Ghobadi A, Tomasson MH, Pusic I, Romee R, Fehniger TA, Stockerl-Goldstein KE, Vij R, Oh ST, Abboud CN, Cashen AF, Schroeder MA, Jacoby MA, Heath SE, Luber K, Janke MR, Hantel A, Khan N, Sukhanova MJ, Knoebel RW, Stock W, Graubert TA, Walter MJ, Westervelt P, Link DC, DiPersio JF, Ley TJ
    N Engl J Med 2016 Nov 24;375(21):2023-2036
  • Late Acute Graft-Versus-Host Disease: A Prospective Analysis of Clinical Outcomes and Circulating Angiogenic Factors
    Holtan SG, Khera N, Levine JE, Chai X, Storer B, Liu HD, Inamoto Y, Chen GL, Mayer S, Arora M, Palmer J, Flowers MED, Cutler CS, Lukez A, Arai S, Lazaryan A, Newell LF, Krupski C, Jagasia MH, Pusic I, Wood W, Renteria AS, Yanik G, Hogan WJ, Hexner E, Ayuk F, Holler E, Watanaboonyongcharoen P, Efebera YA, Ferrara JLM, Panoskaltsis-Mortari A, Weisdorf D, Lee SJ, Pidala J
    Blood 2016 Nov 10;128(19):2350-2358
  • Lung Function Trajectory in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplant
    Cheng GS, Storer B, Chien JW, Jagasia M, Hubbard JJ, Burns L, Ho VT, Pidala J, Palmer J, Johnston L, Mayer S, Crothers K, Pusic I, Lee SJ, Williams KM
    Ann Am Thorac Soc 2016 Nov;13(11):1932-1939
  • Phase I Study of Azacitidine Following Donor Lymphocyte Infusion for Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation
    Ghobadi A, Choi J, Fiala MA, Fletcher T, Liu J, Eissenberg LG, Abboud C, Cashen A, Vij R, Schroeder MA, Pusic I, Stockerl-Goldstein K, Jacoby M, Uy G, DiPersio J, Westervelt P
    Leuk Res 2016 Oct;49:1-6
  • Glycoprotein YKL-40: A Novel Biomarker of Chronic Graft-Vs-Host Disease Activity and Severity?
    Durakovic N, Krecak I, Peric Z, Milosevic M, Desnica L, Pulanic D, Pusic I, Kusec V, Vrhovac R, Pavletic SZ, Nemet D
    Croat Med J 2016 Jun 30;57(3):239-46
  • Transplants for MDS and Quality-Of-Life. But Whose Quality-Of-Life?
    Gale RP, Pusic I
    Bone Marrow Transplant 2016 Aug;51(8):1066-8
  • Biomarker Panel for Chronic Graft-Versus-Host Disease
    Yu J, Storer BE, Kushekhar K, Abu Zaid M, Zhang Q, Gafken PR, Ogata Y, Martin PJ, Flowers ME, Hansen JA, Arora M, Cutler C, Jagasia M, Pidala J, Hamilton BK, Chen GL, Pusic I, Lee SJ, Paczesny S
    J Clin Oncol 2016 Aug 1;34(22):2583-90
  • HLA Disparity Is Not Inconsequential in Peripheral Blood T-Replete Haploidentical Hematopoietic Stem Cell Transplantation
    Rashidi A, DiPersio JF, Westervelt P, Abboud CN, Schroeder MA, Pusic I, Cashen AF, Fehniger TA, Romee R
    Bone Marrow Transplant 2016 Sep;51(9):1275-8
  • Peritransplant Serum Albumin Decline Predicts Subsequent Severe Acute Graft-Versus-Host Disease After Mucotoxic Myeloablative Conditioning
    Rashidi A, DiPersio JF, Westervelt P, Abboud CN, Schroeder MA, Cashen AF, Pusic I, Romee R
    Biol Blood Marrow Transplant 2016 Jun;22(6):1137-41
  • A Phase I Study of Carfilzomib for Relapsed or Refractory Acute Myeloid and Acute Lymphoblastic Leukemia
    Wartman LD, Fiala MA, Fletcher T, Hawkins ER, Cashen A, DiPersio JF, Jacoby MA, Stockerl-Goldstein KE, Pusic I, Uy GL, Westervelt P, Vij R
    Leuk Lymphoma 2016 Mar;57(3):728-730
  • Phase-1/-2 Study of Pomalidomide in Chronic GvHD
    Pusic I, Rettig MP, DiPersio JF, Bauer S, McFarland K, Gale RP, Pavletic SZ
    Bone Marrow Transplant 2016 Apr;51(4):612-614
  • Late Acute and Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
    Arora M, Cutler CS, Jagasia MH, Pidala J, Chai X, Martin PJ, Flowers ME, Inamoto Y, Chen GL, Wood WA, Khera N, Palmer J, Duong H, Arai S, Mayer S, Pusic I, Lee SJ
    Biol Blood Marrow Transplant 2016 Mar;22(3):449-55
  • Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome After Hematopoietic Cell Transplantation
    Williams KM, Cheng GS, Pusic I, Jagasia M, Burns L, Ho VT, Pidala J, Palmer J, Johnston L, Mayer S, Chien JW, Jacobsohn DA, Pavletic SZ, Martin PJ, Storer BE, Inamoto Y, Chai X, Flowers ME, Lee SJ
    Biol Blood Marrow Transplant 2016 Apr;22(4):710-6
  • A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis After Hematopoietic Cell Transplantation
    Arai S, Pidala J, Pusic I, Chai X, Jaglowski S, Khera N, Palmer J, Chen GL, Jagasia MH, Mayer SA, Wood WA, Green M, Hyun TS, Inamoto Y, Storer BE, Miklos DB, Shulman HM, Martin PJ, Sarantopoulos S, Lee SJ, Flowers ME
    Clin Cancer Res 2016 Jan 15;22(2):319-327
  • Predictors of Survival, Nonrelapse Mortality, and Failure-Free Survival in Patients Treated for Chronic Graft-Versus-Host Disease
    Palmer J, Chai X, Pidala J, Inamoto Y, Martin PJ, Storer B, Pusic I, Flowers ME, Arora M, Pavletic SZ, Lee SJ
    Blood 2016 Jan 7;127(1):160-6
  • Genomic Analysis of Germ Line and Somatic Variants in Familial Myelodysplasia/Acute Myeloid Leukemia
    Churpek JE, Pyrtel K, Kanchi KL, Shao J, Koboldt D, Miller CA, Shen D, Fulton R, O'Laughlin M, Fronick C, Pusic I, Uy GL, Braunstein EM, Levis M, Ross J, Elliott K, Heath S, Jiang A, Westervelt P, DiPersio JF, Link DC, Walter MJ, Welch J, Wilson R, Ley TJ, Godley LA, Graubert TA
    Blood 2015 Nov 26;126(22):2484-90
  • Maintenance Therapy With Decitabine After Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
    Pusic I, Choi J, Fiala MA, Gao F, Holt M, Cashen AF, Vij R, Abboud CN, Stockerl-Goldstein KE, Jacoby MA, Uy GL, Westervelt P, DiPersio JF
    Biol Blood Marrow Transplant 2015 Oct;21(10):1761-9
  • Measuring Therapeutic Response in Chronic Graft-Versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: IV. The 2014 Response Criteria Working Group Report
    Lee SJ, Wolff D, Kitko C, Koreth J, Inamoto Y, Jagasia M, Pidala J, Olivieri A, Martin PJ, Przepiorka D, Pusic I, Dignan F, Mitchell SA, Lawitschka A, Jacobsohn D, Hall AM, Flowers ME, Schultz KR, Vogelsang G, Pavletic S
    Biol Blood Marrow Transplant 2015 Jun;21(6):984-99
  • Conservative Management of Pneumatosis Intestinalis After Allogeneic Hematopoietic SCT
    Bhamidipati PK, Ghobadi A, Bauer S, DiPersio JF, Pusic I
    Bone Marrow Transplant 2014 Nov;49(11):1436-8
  • A Phase I Dose Escalation Study of Oral Bexarotene in Combination With Intravenous Decitabine in Patients With AML
    Welch JS, Niu H, Uy GL, Westervelt P, Abboud CN, Vij R, Stockerl-Goldstein KE, Jacoby M, Pusic I, Schroeder MA, DiPersio JF, Cashen AF
    Am J Hematol 2014 Aug;89(8):E103-8
  • Protective Effect of Cytomegalovirus Reactivation on Relapse After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients Is Influenced by Conditioning Regimen
    Manjappa S, Bhamidipati PK, Stokerl-Goldstein KE, DiPersio JF, Uy GL, Westervelt P, Liu J, Schroeder MA, Vij R, Abboud CN, Fehniger TA, Cashen AF, Pusic I, Jacoby M, Meera SJ, Romee R
    Biol Blood Marrow Transplant 2014 Jan;20(1):46-52
  • Economic Evaluation of Plerixafor for Stem Cell Mobilization
    Kymes SM, Pusic I, Lambert DL, Gregory M, Carson KR, DiPersio JF
    Am J Manag Care 2012 Jan;18(1):33-41
  • Rationale and Design of the Chronic GVHD Cohort Study: Improving Outcomes Assessment in Chronic GVHD
    Chronic GVHD Consortium (Contributors include: Pusic I)
    Biol Blood Marrow Transplant 2011 Aug;17(8):1114-20
  • Update on Clinical Experience With AMD3100, an SDF-1/CXCL12-CXCR4 Inhibitor, in Mobilization of Hematopoietic Stem and Progenitor Cells
    Pusic I, DiPersio JF
    Curr Opin Hematol 2010 Jul;17(4):319-26
  • The Use of Growth Factors in Hematopoietic Stem Cell Transplantation
    Pusic I, DiPersio JF
    Curr Pharm Des 2008;14(20):1950-61
  • Impact of Mobilization and Remobilization Strategies on Achieving Sufficient Stem Cell Yields for Autologous Transplantation
    Pusic I, Jiang SY, Landua S, Uy GL, Rettig MP, Cashen AF, Westervelt P, Vij R, Abboud CN, Stockerl-Goldstein KE, Sempek DS, Smith AL, DiPersio JF
    Biol Blood Marrow Transplant 2008 Sep;14(9):1045-56
  • Pseudoautologous Blood Stem Cell Transplantation for Refractory Chronic Graft-Versus-Host Disease
    Pusic I, Pavletic SZ, Kessinger A, Tarantolo SR, Bishop MR
    Bone Marrow Transplant 2002 Apr;29(8):709-10

Book Chapters

  • Stem Cell Transplantation
    Kramer M, Tarun T, Pusic I
    In: The Washington Manual of Cardio-Oncology: A Practical Guide for Improved Cancer Survivorship (Lenihan D, ed), in press 2021
  • Chronic Graft-Vs-Host Disease
    Pusic I, Pavletic SZ
    In: Lazarus HM (ed), Hematopoietic Transplantation: Bone Marrow, Blood and Cell Therapies. Cambridge University Press, 2014
  • Chronic Graft-Vs-Host Disease
    Pusic I, Vogelsang GB, Pavletic SZ
    In: Wingard JR (ed), Hematopoietic Stem Cell Transplantation: A Clinician’s Handbook, (pp 345-364). Bethesda: AABB, 2009